viewOxford Pharmascience Group Plc

Oxford Pharmascience wins innovation award


Drug delivery specialist Oxford Pharmascience (LON:OXP) has won an award for innovation.

The Innovation Award 2013 was made by Aché Laboratórios, OXP’s partner in Brazil, and it recognises the success of the Inellare product, which was launched by the partners last year.

Inellare is growing strongly with both companies working in close partnership to support a growing pipeline of products under the brand, Oxford Pharmascience (OXP) said.

Aché Laboratórios has a strong presence in Brazil, which is one of the world’s most dynamic, emerging pharmaceutical markets, according to OXP.

"We are delighted to be recognised as the most innovative supplier by our partner Aché, one of the largest emerging markets pharmaceutical companies,” OXP’s chief technology officer Marcelo Bravo said.

“This demonstrates our business model of developing and licensing innovative best-in-class products to major pharmaceutical companies and validates our ability to deliver.

“We look forward to continuing to work with Aché Laboratorios to deliver innovation in Brazil and the rest of South America".

Quick facts: Oxford Pharmascience Group Plc

Price: - -

Market: AIM
Market Cap: -

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...



Full interview: Alkane Resources hits almost 700 metres of mineralisation in...

Alkane Resources Ltd (ASX:ALK) managing director Nic Earner updates Proactive on follow-up drill results from the Boda prospect within the wider Northern Molong Porphyry Project (NMPP) near Orange in New South Wales. The drilling is part of a 5,000-metre diamond core drilling exploration...

4 hours, 56 minutes ago

2 min read